PhosPrint P.C.

Θερμές ευχές από όλους μας στη PhosPrint P.C. για τη Νέα Χρονιά. Το 2024 ήταν ακόμα μια σημαντική χρονιά για την εταιρία μας, με την πετυχημένη προ κλινική δοκιμή, ακόμα ένα βραβείο και πολλές ευκαιρίες για την παρουσίαση της καινοτόμου τεχνολογίας μας. Με μια ξεχωριστή συνέντευξη κλείσαμε τη χρονιά, και ευχαριστουμε τη Η ΝΑΥΤΕΜΠΟΡΙΚΗ | NAFTEMPORIKI tv και τον Takis Spiliopoulos για την φιλοξενία της CEO μας Ioanna Zergioti. Warm wishes from all of us at PhosPrint P.C. for the New Year. 2024 was another important year for our company, with the successful pre-clinical trial, another award and many opportunities to present our innovative technology. We closed the year with a special interview! Many thanks to Naftemporiki tv and Takis Spiliopoulos for hosting our CEO Ioanna Zergioti! https://lnkd.in/dkmDi-Tq

Thank you European Innovation Council and SMEs Executive Agency (EISMEA) and WLOUNGE for a memorable #Tech Gala Awards 2024 in Berlin last Saturday, December 14. Our CEO Ioanna Zergioti and Biologist Eleni Damianidou were honored and delighted to represent our company - one of the 3 finalists at the Med Tech category- at this exceptional event!

excellent news for PhosPrint P.C. to be on the three finalists at the medtech category. The awards will be announced at the WLOUNGE Tech Gala in Berlin this Saturday 14/12 at the Rotes Rathaus, Berlin. Ioanna Zergioti and Eleni Damianidou will be there, stay tuned! Grateful to European Innovation Council and SMEs Executive Agency (EISMEA) and to the WLOUNGE

On behalf of all of us at PhosPrint P.C., a huge thank you to the European Innovation Council and SMEs Executive Agency (EISMEA) for another opportunity to present our innovative technology, this time at the WLOUNGE Tech Gala Awards in Berlin!! #medtech #innovation #regenerative medicine

Many thanks Stamatiki Kritas and Hellenic Biocluster (HBio) for the shout out and the continuous support of our efforts to make our innovative technology known to #healthcare audiences and investors in Europe.

What an honor, privilege and opportunity for us to present at the HealthTech Investor Summit from 9-11 December 2024 in picturesque Bruges in Belgium. If you're attending HTIS, don’t miss the opportunity to learn more about our revolutionary technology. We will present a pioneering advancement in regenerative medicine and urology: our in vivo laser bioprinting system, which enables precision bladder repair directly within the patient's body. Utilizing state-of-the-art laser-guided cell deposition, PhosPrint offers a minimally invasive solution for patients suffering from bladder cancer. Our approach ensures targeted tissue regeneration, minimizes recovery time, and reduces risks associated with traditional surgical methods. #medtech #innovation 📍 Event: HTIS 2023 📅 Date: 9–11 December 📌 Location: Bruges, Belgium

What an honor, privilege and opportunity for us to present at the HealthTech Investor Summit from 9-11 December 2024 in picturesque Bruges in Belgium. If you're attending HTIS, don’t miss the opportunity to learn more about our revolutionary technology. We will present a pioneering advancement in regenerative medicine and urology: our in vivo laser bioprinting system, which enables precision bladder repair directly within the patient's body. Utilizing state-of-the-art laser-guided cell deposition, PhosPrint offers a minimally invasive solution for patients suffering from bladder cancer. Our approach ensures targeted tissue regeneration, minimizes recovery time, and reduces risks associated with traditional surgical methods. #medtech #innovation 📍 Event: HTIS 2023 📅 Date: 9–11 December 📌 Location: Bruges, Belgium

🚀 Exciting News! 🌟 We’re thrilled to announce that PhosPrint will be showcasing at HTIS (Health Tech Investor Summit) in Bruges from 9th to 11th December! We will present a pioneering advancement in regenerative medicine and urology: our in vivo laser bioprinting system, which enables precision bladder repair directly within the patient's body. Utilizing state-of-the-art laser-guided cell deposition, PhosPrint offers a minimally invasive solution for patients suffering from bladder cancer. Our approach ensures targeted tissue regeneration, minimizes recovery time, and reduces risks associated with traditional surgical methods. If you're attending HTIS, don’t miss the opportunity to learn more about this revolutionary technology. Let’s explore how we can innovate together! 📍 Event: HTIS 2023 📅 Date: 9–11 December 📌 Location: Bruges, Belgium #Innovation #HTIS #TechSummit #PhosPrint #Networking

🎆We are super excited and super proud to be included in the Tech Awards Gala 2024 #WTA2024 in Berlin, as one of the 3 Top Finalists in the MedTech category. 💥 Thank you @WLOUNGE for the recognition and the opportunity to present our innovation!! 📅 Date: December 14, 2024 📍 Venue: Rotes Rathaus, Berlin

Join us at the #EUeic Pavilion at MEDICA - Leading International Trade Fair where with 17 other innovative healthcare companies we are showcasing our innovations!